Evidence map›Paper›PMID 35230241›Full record

ArticleJournal of medical Internet research2022

Patient Influencers: The Next Frontier in Direct-to-Consumer Pharmaceutical Marketing.

Erin Willis, Marjorie Delbaere

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Educators, Not Influencers: Health Content Creator Perspectives on Research Recruitment Collaboration.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. 'Public health nutrition · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Erin Willis *Department of Advertising, Public Relations, and Media Design, University of Colorado Boulder, Boulder, CO, United States.ORCID 0000-0002-1582-0867
Marjorie Delbaere *Edwards School of Business, University of Saskatchewan, Saskatoon, SK, Canada.ORCID 0000-0002-4782-5769

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Social media influencers are becoming an increasingly popular strategic communication tactic used across industry verticals, including entertainment, fashion, and beauty, to engage directly with consumers. Pharmaceutical companies have also recently entered the social media marketing arena and-within the bounds of governmental regulations-have found ways to build relationships directly with patients using covert persuasion tactics like partnering with social media influencers. Due to consumers' negative perceptions of pharmaceutical companies, it makes sense that new marketing tactics are being used to establish and improve relationships with consumers. Previous research well documents the ethical dilemmas of direct-to-consumer advertising, and there is recent burgeoning literature on online covert marketing tactics. The academic and medical literature, however, is behind in regard to social media influencers used in health and medicine. This paper highlights and defines terms used in industry practice, and also calls for more investigation and sets forward a research agenda. As consumers spend more time online and patients continue to consult social media for health information, it is important that this new marketing trend does not go unnoticed.

Indexed as

Direct-to-Consumer AdvertisingSocial MediaDrug IndustryHumansMarketingPharmaceutical PreparationsPublicationsPharmaceutical Preparationsadvertisingdirect-to-consumer advertisingethicshealthinfluencersmarketingpharmaceutical marketingpharmaceuticalsrelationship marketingsocial media

Identifiers

PMID35230241
PMCPMC8924782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.